Live Webinar: European Pharmacopoeia "Balances for Analytical Purposes"

Compliance with Ph. EUR. General Chapter 2.1.7 

This is a live webinar about the new Ph. EUR. General Chapter 2.1.7. As of January 1, 2022, the European Pharmacopoeia is a legally binding reference for the quality control of medicines.

In this webinar you will learn everything about the new Ph. EUR. General Chapter 2.1.7 "Balances for Analytical Purposes". As of January 1, 2022, the European Pharmacopoeia is a legally binding reference for the quality control of medicines in European member states and for any pharmaceutical company exporting to the European market. The Pharmacopoeia shares a similar legal status as the USP compendium in the United States. In fact, the requirements of Ph. EUR. include the same tests and criteria as USP General Chapter 41 - but Ph. EUR. states explicitly that the calibration must include the measurement uncertainty and adds the concept of as-found and as-left calibrations.

In this webinar you will learn:

  • The legal status and scope of the European Pharmacopoeia
  • The main elements of Chapter 2.1.7 "Balances for Analytical Purposes"
  • The similarities and differences between Ph. EUR. and USP requirements
  • Key Weighing Principles and Considerations to Mitigate Environmental Factors That Can Affect Balance Performance
  • Why calibration is an essential part of a quality assurance system and should include an explanation of the measurement uncertainty
  • The specific performance checks needed to assess the accuracy and precision of an instrument
  • How GWP, a Scientific Standard, Supports General Chapter 2.17 Compliance
  • Where further information can be obtained on balance sheet lifecycle management in a regulated environment.